Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Acacia Subsidiary Enters into Settlement and Patent License Agreement with Smartware Group, Inc.
Print
Alert
Acacia (NASDAQ:ACTG)
Intraday Stock Chart
Today : Tuesday 24 December 2013
Click Here for more Acacia Charts.
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Automated Facilities Management Corporation subsidiary has entered into a settlement and patent license agreement with Smartware Group, Inc. The agreement resolves litigation that was pending in the United States District Court for the District of New Hampshire.
ABOUT ACACIA RESEARCH CORPORATION
Founded in 1993, Acacia Research Corporation (NASDAQ: ACTG) is the industry leader in patent licensing. An intermediary in the patent marketplace, Acacia partners with inventors and patent owners to unlock the financial value in their patented inventions. Acacia bridges the gap between invention and application, facilitating efficiency and delivering monetary rewards to the patent owner.
For more information, visit: www.acaciaresearch.com
you mean the collapse ?
Seriously looking to buy here,any recommendations as to when to get in....I like your post and it's very informative,but was just wondering at what pps do you think is a good entry point>>>? All the cash build-up can be quickly gobbled up by litigation,and I see a decrease of around 100million so far this year?
Consecutive quarters of poor performance has had a decisive negative impact on the stock. The break below $20, and now below $15 indicates that there could be more pain in the offing. The stock needs to bounce immediately with good volumes, otherwise it may go down by another 10%. The main problem is the unpredictability in the earnings which makes it difficult to take a call on the future valuations. The fluctuations in the top line and the bottom line have decreased the faith of the investors over the last few quarters. The stock is now one third of its peak value in September 2011. The revenue stream is not diversified and there is excessive dependence on a few licensees. Even other similar sized companies may have a similar problem, but it is important for Acacia to do something about it fast. Lawsuits outcomes are unpredictable, and many companies in the sector are making efforts to diversify the IPR portfolio and focus on licensing revenues to get regular inflow. Marathon Patents Group (MARA) is attempting a balance between diversified licensing revenue stream and enforcement through litigation. Zacks now has a strong sell rating on Acacia, and the full year EPS for 2013 is estimated at 33 cents which indicates that the valuations are likely to remain high. The counter lawsuit by Microsoft (MSFT) has also had an impact on the sentiments. Microsoft has accused Acacia of claiming payments based on litigation tactics rather than demanding payments based on the actual valuation of its patents. The good part is that the company is debt free and has a huge amount of cash. However, the recently announced repurchase program will lead to some depletion over the next few quarters. The program is for purchase in the aggregate up to $70 million of its common stock through the period ending May 14, 2014.
The Q3'13 earnings were bad as the revenues declined sharply both on a yoy and sequential basis. Even the net loss increased on a yoy and a sequential basis. The ttm figures indicate that 2013 will be a bad year for the company. Consequently, the earnings release led to sharp decline in the stock, and the after hours quotes are indicating that there could be more pain in store. It will be difficult to get out of this hole as the company has posted bad numbers for three quarters in a row. It is now a declining trend, and there could be downgrades from analysts. The trading volume was 1.4 million, but it seems that the entire impact of the numbers has not been factored yet. These earnings were extra crucial, and now the stock may go to much lower levels over the next few months. It has broken the strong supports around $20-21 and now may go all the way to $15-16. The Q3'13 revenues were $15.5 million compared $34.9 million in Q3'12 & $23 million in Q2'13. The net loss was substantially higher at $15.7 million compared to $6.6 million in Q3'12 and $12.5 million in Q2'13. In the third quarter of 2013, three licensees individually accounted for 34%, 31% and 19% of revenues, as compared to five licensees individually accounting for 30%, 13%, 10%, 10%, and 10% of revenues recognized during the third quarter of 2012. This points to higher dependence on a few clients for majority of the revenues. Diversity is important to reduce uncertainty and risk, especially in view of increased competition in the sector. There are patent assertion entities like Spherix (SPEX) which are working to increase the diversity of their patent portfolios. Several companies are more aggressive, and hence it is important for Acacia to diversify to smoothen the curve.
The upcoming earnings will be extra crucial for Acacia. The last two earnings have led to huge declines in the stock, and it is imperative that the company is able to beat the estimates this time around. The revenue for the last 4 quarters (ttm) is $201 million and the net loss is $4.19 million. So to show growth in 2013, it has to do great in the balance two earnings. Most probably, the exponential growth of past few years will not be repeated this year. The revenues have fluctuated and the Q2'13 was particularly bad with 54% decline in the topline on a yoy basis, and an even larger drop sequentially. In Q3'12 the revenues were around $35 million and the net loss was around $6.62 million. The analysts have diverse opinions about the stock, though the average price target of $28 indicates significant upside from current levels. Zacks has upgraded Acacia from underperform to neutral rating, and the target is $23.50. Standpoint Research has a buy rating and with a PT of $33, while Barclays Capital has reduced the PT from $28 to $23. JPMorgan Chase has also reduced the target to $34 from $40, though it maintains an overweight stance. The market is growing and Acacia is in a position to leverage the growth to its advantage. Competition may also increase over time. Spherix (SPEX) has changed its business model to pursue patent monetizing strategies. Spherix has filed a few claims against big organizations recently. In case the earnings for Q3'13 are better than estimates, the positive reaction may be aggravated by the shorts. As of September 13, the shorts were at 8%, but the days required to cover them is around 14.5 days. Hopefully, the earnings will provide the positive trigger and the uptrend will resume.
A recent article on seekingalpha is remarkably positive on Acacia. The author contends that Acacia is a long misunderstood company with low valuations compared to its peer group stocks, high level of underused intellectual property, high capital, little direct competition and strong balance sheet, with at least 25% of market capital in its balance sheet. The article is interesting and gives good information about the industry and the company. The potential of the company is evident from the performance over the last few years. It has grown at an exponential pace, though the last couple of quarters have been particularly bad. The stock performance has also not been very good as it has remained volatile, and declined over the past couple of years. The opportunity is immense as more and more companies are realizing the potential of monetizing their IPR assets, but they do not have the capability to do so themselves. Acacia offers the required services for these companies to achieve their objective. Patent monetizing business has grown tremendously over the last few years with even smaller companies like Marathon Patents Group (MARA) taking on bigger companies like Cisco, Dell etc. However, the potential of Acacia has to be reflected in the earnings of the next few quarters otherwise the sentiments may deteriorate. So far, the stock has shown some resilience by taking support around $20-21. Those levels need to be kept in mind. The correction in the stock has made the dividend yield much better. However, even dividends ultimately depend on financial performance, and payouts from reserves cannot be sustained. The performance in the next quarter will be crucial, and the good part is that the expectations will be much lower at that time. Some may like to see its performance in Q3'13 before considering a dip for the long term.
The decline in revenues is surely alarming because of its magnitude. Companies have to maintain a level of revenues to be able to meet the fixed costs. This is especially true if the margins are not very high. The net loss in the second quarter, has stretched the ttm valuations even further. In fact, it is now carrying a loss on a ttm basis. The outlook has become negative. Wild fluctuations make it difficult for analysts to predict the forward P/E etc. The good part about Acacia is that the company does not have any debt on books. It has a good amount of cash , and the high current ratio indicates good liquidity position. Another positive is that it is operating in a business segment with good growth. There are several opportunities of patent acquisition / monetizing. However, the growth opportunities are also attracting competition as companies like Spherix (SPEX) have also become more aggressive with several acquisitions. Acacia manages hundreds of patents collections in the technology, power and other segments. The recent poor performance has been explained by the firm by stating that the financial terms of its patent acquirement contracts vary based on the sum of incomes documented each phase, the blend of copyright portfolios yielding income and the terms of contracts accomplished during the period. The bottomline was affected as the lawsuit and licensing expenditures increased substantially, mainly due to increase in examination and enforcement expenditures and advanced 3rd party consulting costs connected to licensing and enforcement plans. The company accomplished 43 novel contracts during the quarterly period compared to 38 during the last year period. So the potential is definitely there, but the last few quarters are reflecting that the company is not able to leverage the growth opportunities to its advantage. Hopefully, the next quarter will be better, and the company will get consistent over the longer term. More negative surprises will definitely cause serious damage.
The stock seems to be waiting for some push to take it out of the range. It has recovered a substantial portion of the fall from $29 to $21, but has not gained decisive strength to take it above crucial levels. The most likely push will be the earnings, but that is a little far away. Some news related to acquisition of patents or licensing arrangements may do the trick. But till that, it may remain subdued. The fall in April was backed by huge volumes, and the stock has managed to do well to recover from the lows. Its main strength lies in the patent assets it owns which provide it with licensing / other revenues. The earnings, have been a little unstable over the past few quarters, and that is the reason why the stock has remained relatively volatile. Growth in patent monetizing / licensing business has increased the focus of small and big companies on the IPR assets they own. Companies are trying to optimize the values of the technologies they possess by taking professional advise. Smaller companies like PLC Systems (PLCSF), a medical device company, work to build a patent portfolio around a single product (RenalGuard) which they possess. Other companies attempt to diversify their portfolio and get patents which provide them with licensing revenues. For Acacia, the valuations are relatively high as compared with the peers. The P/E is 82 and P/S is more than 5. The profit margin is low at around 6%, and the sentiments have been adversely affected after the last earnings. The street downgraded the stock to hold recently, but was confident about the liquidity position. The prospects for the company are good, and if it can provide a positive surprise in the next earnings, then the sentiment may change significantly.
Monday 3 June 2013 Acacia Names Leading IP Executive from Energy Industry to Management Team
Acacia (NASDAQ:ACTG)
Intraday Stock Chart
:
.
Acacia Research Corporation (Nasdaq: ACTG) announced today that Charlotte Rutherford has joined Acacia Research Group LLC as Senior Vice President.
Ms. Rutherford was most recently Deputy General Counsel, Intellectual Property for Schlumberger Limited, and designed/restructured and managed the global IP departments at Schlumberger, Colgate-Palmolive and Conoco over the past 12 years.
She was previously Vice President and Associate General Counsel Intellectual Property for Colgate-Palmolive Inc. and Chief Intellectual Property Counsel for Conoco Inc.
During her IP career, Ms. Rutherford has developed global IP licensing programs for several Fortune 500 companies with thousands of patents covering energy, electronics, specialty materials, NMR and sensor technologies that resulted in major revenue opportunities.
Earlier in her career, Ms. Rutherford was General Counsel of Power Management and Advanced Magnetics for Honeywell International, a partner and legal manager of the chemical and pharmaceutical intellectual property practice with Gibbons, Assistant General Counsel for the Minerals Technologies formerly a division of Pfizer, Inc. and was Senior Counsel at Amerada Hess Corporation and Shell Oil Company.
Ms. Rutherford holds a Bachelor and Master of Science in Engineering from Auburn University, an MBA from Rutgers University and a Juris Doctor from Loyola University.
“Joining the Acacia team provides the opportunity to focus on monetizing energy technologies to foster innovation while increasing our competitiveness in the energy market,” commented Ms. Rutherford.
Acacia Research Corporation’s CEO, Paul Ryan, commented, “Ms. Rutherford’s extensive experience in managing intellectual property issues at leading U.S. companies makes her a great addition to Acacia’s management team as we continue to build the country’s leading patent licensing company.”
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation’s subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research Corporation’s subsidiaries control over 250 patent portfolios, covering technologies used in a wide variety of industries.
Information about Acacia Research Corporation and its subsidiaries is available at www.acaciaresearchgroup.com and www.acaciaresearch.com.
Wow!! ... More Awesome news for Actg...This entire sector is on fire.
I wish I got in actg in the beginning.
The IP sector is the place to be right now for sure!!
.
.
Actg...More awesome news. MARA is the next act!!
.
This entire sector is just starting to heat up. It's the perfect time to get in before it really takes off!
Just take a look at MARA and all the other companies in the IP sector. I believe you will be impressed.
.
More AWESOME NEWS out today! May 24, 2013, 6:00 a.m. EDT
Acacia Subsidiary Enters into Settlement and License Agreement with Red Hat, Inc.
NEWPORT BEACH, Calif., May 24, 2013 (BUSINESS WIRE) -- Acacia Research Corporation ACTG -0.30% announced today that its subsidiary, Business Process Modeling Solutions LLC, has entered into a settlement and license agreement with Red Hat, Inc. This agreement resolves patent litigation that was pending in the United States District Court for the Northern District of Texas.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation's subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research Corporation's subsidiaries control 250 patent portfolios, covering technologies used in a wide variety of industries.
Information about Acacia Research Corporation and its subsidiaries is available at www.acaciaresearchgroup.com and www.acaciaresearch.com.
MARA is going to be the next ACTG. Mark this post.
These 2 companies are too much alike for the pps to be so far apart.
Great sector for investors to get in now! Before it really takes off!
.
This entire sector is getting increasing interest and is just starting its growth.
Very solid company here in a great up and coming sector.
Actg is setting the standard for the industry.
Thanks postyle..saw that now,totally ridiculous and I don't think any investor(or even trader)takes seriously at all.Perfect word you used for these websites as well as posters-professional nuisance!
I've seen this "person" (and his counterpart Finsajeed) post countless spams both here and on IV. It's surprising these sites allow such relentless spam.
There was one ACTG investigation announced on April 23rd by "Shareholders Foundation, Inc." -- a professional nuisance lawsuit instigator that takes frivolity to a new level. I won't post the link publicly as it might serve to forward their agenda.
I realized I was replying to a worthless post,but I didn't want him/her/it to get away without a fight,lol!If it's 'class-action lawsuits' that was being referred to,we all know those scare only amateur traders/investors.And I don't even see one of those silly lawsuits being filed for ACTG!Anyway,you are right,no point wasting time on such meaningless posts.
you are replying to a robot spam machine who frequents many stock boards on multiple forum websites to paste a snippet of text that includes one of the stocks he is promoting (e.g. MARA, SPEX, etc.)
there are many law firms that initiate "shareholder lawsuits" or other actions on nearly any company that suffers a steep decline in price across a small trading window... such as ACTG recently did after earnings
these types of frivolous actions are not uncommon
where did you hear about this investigation that you are talking about? Could you please provide a link?
The bad results have had a huge negative impact on the stock. It went from $29.5 to $21.50 in one day with volumes of nearly 6 million shares. Both revenues and net income plunged. Revenues declined to $76.86 million compared with $99.04 million last year. The net income for the quarter was $5.11 million compared with $49.93 million (YoY). Acacia has meanwhile become relatively more stable and is moving towards the 200 DMA of $26. This level will not be easy to cross. The force of the fall can be gauged with the fact that the 10 day trading volume (1.84 million) average is more than double the average for 3 months (739K). The minor recovery from the recent low has been supported by decent volumes, but till the 200 DMA is crossed, the trend will remain negative. In addition, there is news of an investigation on behalf of investors for potential securities laws violations by Acacia and certain of its directors and officers in connection certain financial statements. There are allegations of material misstatements. This news at a time like this will obviously make things very difficult. The ttm P/E is now 77, and the forward P/E of around 8 has to be reconsidered. Price to sales is nearly 5, and price to book is 1.80. Acacia subsidiary recently acquired 40 patents related to microprocessor and memory technologies as part of its continuous endeavor to expand its patent portfolios. Patent monetizing is big business now with companies even changing their business model to become more focused on optimizing IPR values. Spherix Inc. (SPEX) recently sold its consulting division to concentrate on drug development so that it could build an IPR portfolios. Spherix is into research for drugs for diabetes and other diseases, and the trials have given encouraging results. For Acacia, the good thing is that it is debt free and had good amount of cash on books. Fundamentals apart, the biggest worry now is the investigation.
Fantastic news today.Feels like company decided to take the fight to the naysayers head-on,loving it,lol!
ACTG: $0.50 Annual Dividend, $100 million Share Repurchase Plan
Acacia Research Corporation Announces Adoption of Cash Dividend Policy of $0.50 per Share Annual Dividend, Payment of Initial Quarterly Dividend and Extension of $100 Million Share Repurchase Plan
NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Acacia Research Corporation (ACTG) announced today that its Board of Directors has approved the adoption of a cash dividend policy that calls for the payment of an expected total annual cash dividend of $0.50 per common share, payable in the amount of $0.125 per share per quarter. Under the new policy, the first of the quarterly cash dividends will be paid on May 30, 2013 to shareholders of record at close of business on May 3rd, 2013. Future cash dividends are expected to be paid on a quarterly basis and will be at the discretion of the Board of Directors.
Acacia Research Corporation CEO, Paul Ryan, commented, “Our dividend policy announced today is based on the successful growth in our business, our strong balance sheet, and our confidence to continue to generate free-cash flow for our shareholders.”
Acacia also announced that its Board of Directors has approved an extension of its previously announced share repurchase plan from May 15, 2013 until August 15, 2013, which authorizes the Company to purchase up to $100 million of its shares of common stock. Share purchases under this plan will continue to be made in the open market, through block trades, through 10b5-1 plans, or privately negotiated transactions, in accordance with applicable Securities and Exchange Commission rules.
http://finance.yahoo.com/news/acacia-research-corporation-announces-adoption-100000321.html
Bought few more ACTG now @ 22.38,second buy today,hoping for some more quick dips intra-day!
thanks for your insights postyle,very much appreciated.Matches my views exactly.Bought a few today,trying to build a position in this in the next few days,hoping it stays down for a bit.
novice, this is what I posted on Friday @ another site:
Earning Beat, Stock dumped
You have to love these stories. ACTG beats $77 mm vs. $59 mm estimate, and also announces settlement with Yahoo. And then gets hammered.
Looks like some are disappointed with the margins (56%) as well as the size of the AAPL settlement. Rumors also that Soros is selling and there is a pile on effect.
A few thoughts of mine:
1) More proof it makes sense to not hold positions in profitable tech companies (at least without some hedge) through earnings.
2) Focus on margins is missing the big picture. A few deals with large partners skew the overall margin numbers. The partner deals are net positive, so they have been beneficial to the bottom line.
3) Through 3 deals the Adaptix purchase is almost break-even. This portfolio is a future game changer.
4) AAPL still on the hook for additional portfolio licensing/settlements.
5) This could be a great opportunity for anyone not yet in ACTG but always had it on their radar. Long term, I really like this one.
postyle..I think ACTG is another 'misunderstood-by-market' company(like VHC),at least as far as the stock action is concerned.Do you agree?Would love your thoughts on the huge drop on friday,on what I look as wrongly valued quarterly earnings comparisons.Due to this company's specific business model,it should NOT be compared quarter by quarter,IMO.Your thoughts please?
For Acacia, expectations for good growth over the next few years are evident from a low PEG and forward P/E. The company is debt free, and had more than $311 million in cash as on 31st December 2012. The shareholders have been rewarded with excellent returns over the years as the stock has moved 15 times from the $2 levels at which it was trading in 2008. In fact it touched $46 in September 2011 which means that it multiplied 23 times in less than three years. This is a great growth story for investors by any yardstick. This has been supported by the long term fundamental story which has been great, with good growth in revenue / net income. The earnings are about to be released and if there are positive surprises, then the stock will take out the $30 to $32 resistance levels easily. After that, $39 - $40 levels may be challenged over the next few months. The recent patent acquisitions and also settlements of lawsuits by Acacia will also have an impact. The company has a relatively balanced business model and is not purely dependent on patent lawsuits. The revenues have increased and any positives or negatives on any infringement lawsuits are likely to have temporary impact. In fact, this was one of the reasons for analyst JP Moreno to recommend Document Security Systems (NYSE:DSS) in his recent report. Though DSS is likely to benefit tremendously from a lawsuit filed by its subsidiary against Facebook (FB), LinkedIn (LNKD), Novell, Broadvision etc., it is not solely dependent on this. The potential of this lawsuit runs into hundreds of millions but Moreno supports DSS because of its balanced business model, with main focus on the operations (selling security solutions – turnover of $17 million in 2012). Hopefully, Acacia will continue with its good performance.
Acacia has announced that its Advanced Data Access LLC subsidiary, its Smart Memory Solutions LLC subsidiary and its Smart Foundry Solutions LLC subsidiary have entered into a settlement agreement with Toshiba Corporation. As per the company, this agreement resolves litigation that was pending in Courts. This is having a negative impact on the stock and there is some selling pressure. The first support is $29, and below that the 200 DMA ($26) is likely to provide support. The volumes have been low recently and in case there is a correction with volumes, then the supports may be difficult to hold. It is still up substantially from the 52 week low of around $20. The company continues to expand its IPR portfolio as recently its subsidiary acquired 40 patents related to microprocessor and memory technologies. The revenues have increased over the years, and the long term trend remains positive. Based on growth in revenues and net income, the stock has moved from around $2 in November 2008 to around $46 in September 2011 (23 times in 3 years). The decline after that can be considered as a correction in the long term price movement. The price to sales and the P/E indicate that the valuations are not very comfortable, but expectations of future growth make it worth considering for long term investment. This is indicated by a very low PEG of 0.57, and low forward P/E of 11. With zero debt on books and more than $310 million in cash, the balance sheet appears to be strong. Numerous patent infringement cases are making news now and companies have started re-examining the value of the patents / know-how they possess. Spherix Inc. (SPEX), which is into drug development / research, recently sold its consulting division to increase concentration on building its IPR portfolio.
ACTG: Market Analysis
For the last two months the price of Acacia Research Corporation (NASDAQ:ACTG) has shown significant increase to make gainer to its investors. On January 30, 2013 the price was $24.77, which has increased to $30.67 on March 27. Fifty two weeks price range is $19.86-44.98. The average trade volume is also good. Is there any possibility to touch the yearly high price? We have to go inside the company by reviewing recent facts, before making prediction. Acacia Research Corporation is engaged to acquire, develop, license and enforce patented technology. Yesterday, ACTG has announced that its subsidiary, Gametek LLC, has entered into a settlement and license agreement with 6waves LLC, 6waves Technologies, LLC, 6waves US, Inc., and Six Waves Inc. This agreement resolves patent litigation that was pending in the United States District Court for the Southern District of California. We know that the company along with its subsidiaries has been generating revenue from granting of intellectual property, as stated in its official website. As ongoing event, the company has been entering into contractual relations to generate revenue. Meanwhile, ACTG has completed agreement with Micron as well as Webtech Wireless Inc., which in effect is expected to impact on revenue of this company. The above will bring the company to reach at business wining in long term, which may be reflected in stock price as well. ACTG has been making its business comfortable keeping a satisfactory stands. As the market becomes competitive, the company must have to prepare itself to establish a reliable business line for long term survival. In each and every day, there are new competitors entering in to the market to have market share, which is challenging to the existing players. Being a good competitor of ACTG, say, Spherix Incorporated (SPEX) is also preparing to fly by finishing major restructuring, divesting, business acquiring, changing top management, making new business deal with multinational partners, etc. As the overall market trend is positive, I think ACTG will go up like SPEX though some price correction is likely.
Scope to Increase Market Share
According to Acacia Research Corporation (NASDAQ:ACTG), “our operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, if necessary, with the enforcement against unauthorized users of their patented technologies”. ACTG is involved to acquire, develop, license and enforce patented technology. ACTG along with its subsidiaries has been generating revenue from granting of intellectual property, as stated in its official website. The company has been entering into contractual relations to generate revenue. Recently, the company has completed agreement with Micron as well as Webtech Wireless Inc., which in effect is expected to impact on revenue of this company. The company is getting more comfort from its operational environment, market as well as industry. Business scope of IP related companies like ACTG has been growing always. As business becoming more knowledge based, companies feel to make extra protection of their assets by using support from IP. Intellectual property and patent became important issue. The business houses engaged in IP services are making their portfolio size larger by adding new intellectual assets. Thus, Intellectuals forecasts a bright future of this industry in their board room discussions. The industry trend is very positive from the last few years and in 2013 the industry is expected to continue the same trend and to exceed its size $500 billion The industry participants have both opportunities as well as challenges to due to a little bit competition in the market. However, ACTG being a medium size competitor may have to face challenges amid industry growth from both big competitors like Apple, Google, AOL, Microsoft, etc, and small & medium competitors like Marathon Patent Group, Inc. (MARA), SPEX, VRNG etc. MARA is coming with huge business in pipeline.
Another ACTG settlement with Apple today (they settled another case in January). ACTG also announced they settled with Micron.
Very good news.
3 gems from a small cap manager
Bookmark and Share
by Jim Oberweis, Jr., editor The Oberweis Report
Jim Oberweis, Jr.The current climate has pushed many investors to the sidelines. Still, staying out of the market may prove to be the wrong move. Stock valuations remain among the lowest of the past two decades.
Here, we present 3 opportunities from our Model Portfolio: a super cheap China growth story, a patent play with an April court date against Apple, and a data collector for drug developers whose growth prospects are underappreciated.
First up is NQ Mobile (NQ), a Chinese growth stock with a value bent. They are the leading provider of security software (which covers anti-virus, anti-theft, and backup) for smartphones in China. It has a market cap of $316 million, $126 million in cash ($2.47/per ADS) and no debt.
On November 26, the company announced a $20 million stock buyback and management also reported scooping up shares personally earlier this year.
The firm was venture backed by Sequoia. Insiders have skin in the game, owning about half the outstanding shares. We were pleased to see NQ hire Omar Khan, formally the chief product and technology officer of Samsung Mobile, in January 2012.
Here’s the best part: We expect 75% growth in 2013 and shares trade for just 3.5x our expected 2013 earnings after stripping out cash. Too good to be true? Due diligence is harder in China, but we were onsite in Beijing and couldn’t uncover anything unusual.
Advertisement
Banner
These days seemingly everything Chinese is assumed to be a fraud and seems to be priced accordingly. Our view is that NQ is a decent business at a spectacular price and that the share price has been unfairly tarnished with the Chinese ADR stigma.
Second on our list is Acacia Research (ACTG). The shares have had a rough year but the company is still one of our favorite long-term investment ideas.
Acacia has become a leading aggregator of patents, accumulating directly or through joint venture the rights to over 250 patent portfolios related to 3G and 4G wireless technology, semiconductor technology, software, video-on-demand, and medical devices and technologies.
Over the last three years, Acacia has struck major licensing deals with the likes of Oracle, Microsoft, Samsung, and Cisco.
The company has a major patent litigation action against Apple which is scheduled to go to trial next year. Based on the actions of several of Apple’s competitors, we expect a settlement before the trial begins. We believe revenue in 2013 could exceed $300 million and EPS could exceed $3 per share.
In contrast to the first two picks, Medidata Solutions (MDSO) performed exceptionally well in 2012. Still, we think the best is yet to come.
Its main product, Rave, replaces the inefficient, traditional paper-based collection of clinical trial results from multiple sites and patients by providing a single platform to record and analyze results.
Medidata invested heavily in products that complement its core Rave product and the investment is ready for harvest. In the latest quarter, non-Rave sales grew 145%. And in 2Q 2012, a top-ten pharma company signed a contract potentially worth up to $100 million over the next five years.
While the industry can be cyclical, Medidata is the market leader, is expanding share, and is earning juicy margins along the way. They also have $4.80/share in cash and no debt. Shares trade for 32x our 2013 estimate of $1.25.
These three gems highlight our core firm philosophy, which pairs a passion for rapid earnings growth with a love of good bargains. Few are the occasions when a fluid macro environment distracts the bargain shopper enough to yield opportunities like these. Buy them while you can!
Learn more about this financial newsletter at Jim Oberweis' The Oberweis Report.
Article posted on Seeking Alpha. The author Arie Goren selects Acacia Research as meeting his criteria. Here's the article:
http://seekingalpha.com/article/918881-3-oversold-growth-stocks-with-no-debt-ready-to-bounce
3 Oversold Growth Stocks With No Debt Ready To Bounce
I have searched for profitable companies with a very strong growth prospects that do not have any debt at all and that are technically oversold at the moment. Those stocks have a better than average chance of beating the market.
I have elaborated a screening method, which shows stock candidates following these lines. Nonetheless, the screening method should only serve as a basis for further research.
The screen's formula requires all stocks to comply with all following demands:
1. The stock is included in the Russell 3000 index. Russell Investment explanation: "The Russell 3000 Index measures the performance of the largest 3000 U.S. companies representing approximately 98% of the investable U.S. equity market. The Russell 3000 Index is constructed to provide a comprehensive, unbiased, and stable barometer of the broad market and is completely reconstituted annually to ensure new and growing equities are reflected."
2. Earnings growth estimates for the next 5 years (per annum) is greater than 20%.
3. Price to free cash flow is positive, (many investors prefer using free cash flow instead of net income to measure a company's financial performance, because free cash flow is more difficult to manipulate. Free cash flow is the operating cash flow minus capital expenditure).
4. Total debt to equity is zero.
5. RSI (14 days) is above 30 and RSI (14 days) was below 30 in one of the last 3 days. (The Relative Strength Index (RSI) is an oscillator that measures current price strength in relation to previous prices. The classic way to interpret RSI is to look for oversold levels below 30 and overbought levels above 70. When the RSI crosses above the oversold line (30) it is considered buy signal).
Acacia Research Corporation (ACTG)
Acacia Research Corporation develops, licenses, and enforces patented technologies in the United States. It assists patent owners with the prosecution and development of their patent portfolios.
Acacia Research has no debt at all and the company has a low forward P/E of 12.40 and a very low PEG ratio of 0.46. The average annual earnings growth for the past 5 years has been very high at 158% and the average annual earnings growth estimates for the next 5 years is also very high at 38%. On October 02, 2012, Acacia Research announced that it has acquired 7 patent portfolios with over 1,900 patents and applications relating to cardiology and vascular device technology from a leading global medical device company. Such a big move should certainly contribute to the impressive growth of the company. All these factors make the stock quite attractive.
Analyst Lisa Springer who has nearly 25 years of investment research experience wrote an article over at StreetAuthority.com comparing Acacia Research and Apple.
From the article:
"There is an opportunity right now to buy Acacia shares at just 8.9 times forward earnings. This is a huge discount to the stock's five-year average price-to-earnings multiple of 30."
I think it's definitely worth a read:
http://www.streetauthority.com/growth-investing/company-more-profitable-apple-459865
Acacia's MemTech Enters Patent Agreement With Analog Devices
(RTTNews.com) - California-based patent licensing company Acacia Research Corp. (ACTG) Thursday said its subsidiary, MemTech LLC, has entered a license and settlement agreement with Analog Devices, covering patents pertaining to certain MEMS devices.
Acacia Research Corp's subsidiaries control over 200 patent portfolios, covering technologies used in a wide variety of industries, said Acacia in a statement.
Wednesday, Acacia Research closed at $26.18 on the Nasdaq.
For comments and feedback: contact editorial@rttnews.com
http://www.rttnews.com
Acacia Research has the Highest Revenue Per Employee in the Research and Consulting Services Industry
COMTEX reported:
"Analysts use RPE as a measure to compare the productivity of companies in the same industry. Acacia Research ranks highest with a an RPE of $4.6 million. FTI Consulting is next with a an RPE of $598,000."
Ben James at law360.com reported that Acacia Research Corp. subsidiary View 360 Solutions LLC served Google Inc. with a lawsuit in New York federal court on Friday.
Acacia is claiming that Google's Street View feature infringes eight patents.
Highlights of the J.P. Morgan research note issued last Friday on ACTG (This comes from a poster at stockhouse.com.)
J.P. Morgan reccommends Acacia Research as an Overweight with a $55.00 price target.
Note from JPMorgan on ACTG & Apple
Acacia Research Corp. Overweight
Apple Trial Results - Implications for ACTG - Positive -
We believe the Apple-Samsung trial verdict underscores the value of key smartphone patents, and immediately benefits Acacia by increasing the potential value of the Palm portfolio and by establishing a smartphone software royalty-rate that will likely be of use by ACTG in preparing for the pending trials against
Apple in 2013 and 2014.
We touched base with ACTG management yesterday.
First take: positive.
? Apple prevails against Samsung. The verdict in the Apple-Samsung trial yielded a victory for Apple—$1.05 billion of damages, which could be tripled and lead to an injunction against sale of certain Samsung products in the U.S.
Nearly all Samsung smartphones were deemed to have infringed and Apple was awarded a royalty-rate close to 50% of the level sought, which was between $2.00 and $3.00 per unit, for the utility patents.
The Jury determined that Apple did not infringe any Samsung patents. Samsung might appeal.
Apple is rated Overweight by J.P. Morgan Hardware analyst Mark Moskowitz.
Samsung is rated Overweight by J.P. Morgan's Asia-based analyst JJ Park.
? Generically, this underscores the value of key smartphone software-based utility patents that are not standards essential.
ACTG believes the Access portfolio (Palm portfolio) is one of the most valuable patent portfolios in the smartphone space. In addition, the company has several key patents that are standards essential but not subject to FRAND licensing (e.g., Adaptix).
? Palm portfolio could be of strategic importance. ACTG management believes that fourteen of the patents in the Palm portfolio are of comparable value to the six patents asserted successfully by Apple.
These Palm patents include a GUI intercept for receiving inbound phone-calls, pre-ranking of network compatibility, pre-store of graphics, and data synching. ACTG believes the Palm patent portfolio can be licensed, but this verdict makes the portfolio of
greater interest to a strategic acquirer (e.g., Google/Motorola) in need of an IP portfolio with which to defend against Apple.
Samsung’s weak smartphone patent portfolio sends a warning signal to other OEMs.
? Apple verdict sets a precedent that could potentially benefit Acacia. Apple believes its utility patents should command a royalty rate of between $2.00 and $3.00 per smartphone unit. ACTG has several suits against Apple, two of which already have trial dates (April 2013 and June 2014). Apple has shipped nearly 250 million smartphones since 2007 and over 80 million iPads.
ACTG believes all these products infringe on the Palm patents. We sense that ACTG management seeks a settlement with Apple that will be in the hundreds of millions (for prior period shipments, alone), much larger than any prior term deal.
~ Monday! $ACTG ~ Q2 Earnings alerted as posted, pending or coming soon! In Charts and Links Below!
~ $ACTG ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=ACTG&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=ACTG&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=ACTG
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ACTG#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ACTG+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ACTG
Finviz: http://finviz.com/quote.ashx?t=ACTG
~ Marketwatch: http://www.marketwatch.com/investing/stock/ACTG/insideractions
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ACTG >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
<<< $ACTG Links! >>> ~ MAC's Quick DD Links without the charts.
PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/ACTG
OTC Markets Company Info ~ http://www.otcmarkets.com/stock/ACTG/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/ACTG/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/ACTG/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/ACTG/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/ACTG/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/ACTG/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/ACTG/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/ACTG/research
Google Finance Summary ~ http://www.google.com/finance?q=ACTG
Google Finance News ~ http://www.google.com/finance/company_news?q=ACTG
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=ACTG
Google Finance Financials ~ http://www.google.com/finance?q=ACTG&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=ACTG
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=ACTG&histperiod=weekly#
Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=ACTG+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=ACTG+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=ACTG+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=ACTG
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=ACTG+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=ACTG+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/ACTG
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/ACTG
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=ACTG+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=ACTG+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=ACTG+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=ACTG+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=ACTG+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=ACTG+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=ACTG+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=ACTG+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=ACTG+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=ACTG+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=ACTG+Cash+Flow&annual
FINVIZ ~ http://finviz.com/quote.ashx?t=ACTG&ty=c&ta=0&p=d
Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=ACTG
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=ACTG
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=ACTG
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=ACTG
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=ACTG
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=ACTG&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260
CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=ACTG&exchange=US
Barchart Quote ~ http://barchart.com/quotes/stocks/ACTG?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/ACTG
Barchart Options Quotes ~ http://barchart.com/options/stocks/ACTG
Barchart Technical Chart ~ http://barchart.com/charts/stocks/ACTG&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/ACTG&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/ACTG
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=ACTG
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/ACTG
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/ACTG
Barchart News Headlines ~ http://barchart.com/news/stocks/ACTG
Barchart Profile ~ http://barchart.com/profile//ACTG
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=ACTG&view=key_statistics
OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=ACTG&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=ACTG&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=ACTG&MarketTicker=NYSE&Typ=S
Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/ACTG/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/ACTG/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/ACTG/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/ACTG/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/ACTG
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/ACTG/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/ACTG/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/ACTG/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/ACTG/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/ACTG/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/ACTG/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=ACTG&sid=1795093&framed=False
The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=ACTG
Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=ACTG
StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=ACTG&num1=567&cobrand=&mode=stock
StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=ACTG
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=ACTG
AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=ACTG&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8
Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=ACTG.PK&WTmodLOC=C4-Officers-5
StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=ACTG®ion=U
Search NASDAQ ~ http://www.nasdaq.com/symbol/ACTG
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/ACTG/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/ACTG/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/ACTG/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=ACTG&selected=ACTG
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=ACTG&selected=ACTG
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/ACTG/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/ACTG/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/ACTG/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/ACTG/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/ACTG/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/ACTG/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/ACTG/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/ACTG/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/ACTG/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/ACTG/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/ACTG/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/ACTG/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/ACTG/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/ACTG/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=ACTG&selected=ACTG
NASDAQ Financials ~ http://www.nasdaq.com/symbol/ACTG/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/ACTG/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/ACTG/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/ACTG/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/ACTG/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/ACTG/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/ACTG/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/ACTG/insider-trades/sells
The Motley Fool ~ http://caps.fool.com/Ticker/ACTG.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/ACTG/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/ACTG/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/ACTG/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/ACTG/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/ACTG/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/ACTG/Statements.aspx?source=icasittab0000009
MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=ACTG
YCharts ~ http://ycharts.com/companies/ACTG
YCharts Performance ~ http://ycharts.com/companies/ACTG/performance
YCharts Dashboard ~ http://ycharts.com/companies/ACTG/dashboard
InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=ACTG&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=ACTG&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=ACTG&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=ACTG
Zacks Quote ~ http://www.zacks.com/stock/quote/ACTG
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=ACTG
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=ACTG
Knobias ~ http://knobias.10kwizard.com/files.php?sym=ACTG
StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=ACTG
Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/ACTG/HOT_TOPIC.html
Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=ACTG&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=ACTG®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=ACTG®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=ACTG®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=ACTG®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=ACTG®ion=USA&culture=en-us
CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=ACTG
TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=ACTG
OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=ACTG&searcharea=e&image1.x=0&image1.y=0
Insidercow ~ http://www.insidercow.com/history/company.jsp?company=ACTG&B1=Search%21
Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=ACTG
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=ACTG&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null
YouTube Symbol Search ~ http://www.youtube.com/results?search_query=ACTG
Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=ACTG
Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=ACTG
Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=ACTG
Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=ACTG
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=ACTG
Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=ACTG
Investorpoint ~ http://www.investorpoint.com/ enter "ACTG" and click search.
Hotstocked ~ http://www.hotstocked.com/ enter "ACTG" and click search.
Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=ACTG
Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=ACTG
DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=ACTG
SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=ACTG
OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=ACTG
Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "ACTG" and click search.
http://www.coordinatedlegal.com/SecretaryOfState.html
http://regsho.finra.org/regsho-Index.html
http://www.shortsqueeze.com/?symbol=ACTG&submit=Short+Quote%99
DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=ACTG
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=ACTG
Check those searches for recent ACTG mentions. If ACTG is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS
MACDlinks
~ Thursday! $ACTG ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!
~ $ACTG ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=ACTG&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=ACTG&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=ACTG
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ACTG#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ACTG+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ACTG
Finviz: http://finviz.com/quote.ashx?t=ACTG
~ BusyStock: http://busystock.com/i.php?s=ACTG&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ACTG >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
Acacia Research acquires ADAPTIX for $160 mln (ACTG) 36.98 : ADAPTIX has $10 million in cash and "rapidly growing" portfolio of 230 issued and pending patents in 13 countries.
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
111
|
Created
|
04/24/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |